These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6177747)

  • 21. [Comparison of the immunosuppressive effects of 6-mercaptopurine, azathioprine, cyclophosphamide and 036.5122 (Asta) on primary and secondary immune reactions in the mouse].
    Botzenhardt U; Lemmel EM
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1806-8. PubMed ID: 1030111
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of antigen-specific B cells in the induction of SRBC-specific T cell proliferation.
    Malynn BA; Wortis HH
    J Immunol; 1984 May; 132(5):2253-8. PubMed ID: 6201538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of lymphotoxin in antibody-dependent cell-mediated cytotoxicity (ADCC).
    Kondo LL; Rosenau W; Wara DW
    J Immunol; 1981 Mar; 126(3):1131-3. PubMed ID: 6970216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of interferon on antibody-dependent cellular cytotoxicity (ADCC) in chickens.
    Mándi Y; Bakay M; Béládi I
    Acta Microbiol Hung; 1984; 31(2):127-33. PubMed ID: 6464658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reticuloendothelial function in immune-suppressed animals.
    Pisano JC; Patterson JT; Di Luzio NR
    J Reticuloendothel Soc; 1972 Oct; 12(4):361-70. PubMed ID: 4634516
    [No Abstract]   [Full Text] [Related]  

  • 26. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model.
    Senba T; Kuroki M; Arakawa F; Yamamoto T; Kuwahara M; Haruno M; Ikeda S; Matsuoka Y
    Anticancer Res; 1998; 18(1A):17-24. PubMed ID: 9568050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is azathioprine a better immunosuppressive than 6-mercaptopurine?
    Berenbaum MC
    Clin Exp Immunol; 1971 Jan; 8(1):1-8. PubMed ID: 4924940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monocyte cytotoxicity: evidence for multiple mechanisms of in vitro erythrocyte target killing. Trypan blue can both inhibit and enhance target lysis.
    Hall RE; Muchmore AV; Blaese RM
    J Reticuloendothel Soc; 1982 Sep; 32(3):233-46. PubMed ID: 7153988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4+ T cells from mice primed for humoral immunity to sheep erythrocytes (SRBC) specifically inhibit cell-mediated immunity and vice versa.
    Zimecki M; Kapp JA; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):259-64. PubMed ID: 8744645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuftsin: a naturally occurring immunopotentiating factor. I. In vitro enhancement of murine natural cell-mediated cytotoxicity.
    Phillips JH; Babcock GF; Nishioka K
    J Immunol; 1981 Mar; 126(3):915-21. PubMed ID: 6893996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unusually efficient tumor cell lysis by human effectors of antibody-dependent cellular cytotoxicity mediated by monoclonal antibodies.
    Christiaansen JE; Sears DW
    Cancer Res; 1984 Sep; 44(9):3712-8. PubMed ID: 6744288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential patterns of cyclosporine A-induced inhibition of humoral and cellular immune responses to sheep erythrocytes in mice.
    Zimecki M; Wieczorek Z
    Pol J Pharmacol; 2001; 53(5):495-500. PubMed ID: 11990068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective inhibition of inflammatory gene expression in activated T lymphocytes: a mechanism of immune suppression by thiopurines.
    Thomas CW; Myhre GM; Tschumper R; Sreekumar R; Jelinek D; McKean DJ; Lipsky JJ; Sandborn WJ; Egan LJ
    J Pharmacol Exp Ther; 2005 Feb; 312(2):537-45. PubMed ID: 15388785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
    Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The immunoregulatory properties of recombinant human tumor necrosis factor-beta in mice opposite-reacting to antigen].
    Masycheva VI; Fadina VA; Danilenko ED; Sysoeva GM; Ratner GM; Stakheeva MN; Stepovaia EA; Khlusova MIu; Sherstoboev EIu; Pustoshilova NM
    Eksp Klin Farmakol; 1999; 62(4):44-7. PubMed ID: 10513336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME; Hiserodt JC
    J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acceptor site(s) for T cell-replacing factor (TRF) on B lymphocytes. I. TRF-substituting activity of anti-TRF acceptor site(s) antibody in the triggering of B cells.
    Takatsu K; Sano Y; Hashimoto N; Tomita S; Hamaoka T
    J Immunol; 1982 Jun; 128(6):2575-80. PubMed ID: 6978907
    [No Abstract]   [Full Text] [Related]  

  • 38. Regulation of antibody response to SRBC. I. Influence of corpuscular and soluble form of erythrocyte antigen and antigen dose on antibody response in A/J and C57BL/10ScSn mice.
    Ríhová B; Tucková L; Ríha I
    Folia Biol (Praha); 1981; 27(1):1-14. PubMed ID: 7009227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of murine plaque-forming cell responses in vivo by ribavirin.
    Peavy DL; Powers CN; Knight V
    J Immunol; 1981 Mar; 126(3):861-4. PubMed ID: 7007503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologic and physical agents. Immunosuppressive agents.
    Elion GB
    Transplant Proc; 1977 Mar; 9(1):975-9. PubMed ID: 325831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.